Impella

3 · 20 / page

Ask MedXY AI

Latest news

Tag

Cardiologycardiogenic shockImpella

Refining Patient Selection for Microaxial Flow Pumps: The DanGer Shock-like Profile as a Survival Predictor in STEMI-CS

By MedXY|Dec 31, 2025

This study validates the DanGer Shock trial criteria in a real-world registry, demonstrating that patients matching the trial’s profile have significantly better survival outcomes when treated with microaxial flow pumps compared to th

Beyond Survival: Unpacking the Hemodynamic and Metabolic Benefits of Microaxial Flow Pumps in STEMI-Related Cardiogenic Shock

Cardiologycardiogenic shockhemodynamics

Impella

Latest news

Refining Patient Selection for Microaxial Flow Pumps: The DanGer Shock-like Profile as a Survival Predictor in STEMI-CS

Beyond Survival: Unpacking the Hemodynamic and Metabolic Benefits of Microaxial Flow Pumps in STEMI-Related Cardiogenic Shock

Beyond the DanGer Shock Trial: Real-World Outcomes and Risk Stratification in Impella-Treated Patients